KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Non-Current Assets (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Non-Current Assets for 17 consecutive years, with $7.7 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 21.1% to $7.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.4 billion through Dec 2025, up 1491.05% year-over-year, with the annual reading at $7.7 billion for FY2025, 21.1% up from the prior year.
  • Non-Current Assets for Q4 2025 was $7.7 billion at Bio-Rad Laboratories, up from $6.9 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $17.5 billion in Q3 2021, with the low at -$3.1 billion in Q2 2024.
  • Average Non-Current Assets over 5 years is $5.9 billion, with a median of $7.5 billion recorded in 2025.
  • The sharpest move saw Non-Current Assets tumbled 134.58% in 2024, then soared 352.62% in 2025.
  • Over 5 years, Non-Current Assets stood at -$2.0 billion in 2021, then crashed by 36.18% to -$2.7 billion in 2022, then dropped by 1.92% to -$2.8 billion in 2023, then skyrocketed by 329.39% to $6.3 billion in 2024, then grew by 21.1% to $7.7 billion in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $7.7 billion, $6.9 billion, and $7.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.